Literature DB >> 30117634

General Surgery Prioritization Tool: a pilot study.

Rachel J Hunter1, Nicholas Buckley1, Eve L Fitzgerald1, Andrew D MacCormick2, Tim W Eglinton3.   

Abstract

BACKGROUND: The prioritization of elective surgical wait-lists remains a contentious issue. Multiple new tools and systems have been developed to attempt to reliably prioritize patients. This study pilots one such system, the General Surgery Prioritization Tool and compares it to the existing triage system of clinical judgement. The aim was to determine if the new tool reflects clinical judgement. Secondary aims were to assess for any bias in its application to different patient groups or its application by different scorers.
METHOD: A cohort of 392 patients was identified who were wait-listed for non-cancer elective surgery between July 2015 and February 2016. The General Surgery Prioritization Tool was applied after traditional prioritization using clinical judgement. The scores produced by the new tool were compared to the clinical judgement categories. Differences in scores based on gender, ethnicity, age, surgical condition and surgeon were then analysed.
RESULTS: There was statistically significant correlation in the new tool scores with traditional triage groups (P < 0.0001). There were no statistically significant differences in mean scores attributable to gender, age or ethnicity. There were minimal differences in mean scores between common surgical conditions. Except for one outlier the mean scores were consistent across 17 surgeons.
CONCLUSION: This pilot study has found the General Surgery Prioritization Tool to reflect clinical judgement and to be generalizable by age, gender, ethnicity and prioritizing surgeon. The tool is at least as clinically reliable as traditional methods in the triage for elective general surgery with the advantage of being a more explicit process.
© 2018 Royal Australasian College of Surgeons.

Entities:  

Keywords:  General Surgery Prioritization Tool; prioritization; triage

Mesh:

Year:  2018        PMID: 30117634     DOI: 10.1111/ans.14703

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  2 in total

1.  Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists.

Authors:  Tim Raine; Maria Angeliki Gkini; Peter M Irving; Arvind Kaul; Eleanor Korendowych; Philip Laws; Amy C Foulkes
Journal:  BioDrugs       Date:  2021-02-26       Impact factor: 5.807

2.  Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic.

Authors:  John R de Almeida; Christopher W Noel; David Forner; Han Zhang; Anthony C Nichols; Marc A Cohen; Richard J Wong; Caitlin McMullen; Evan M Graboyes; Vasu Divi; Andrew G Shuman; Andrew J Rosko; Carol M Lewis; Ehab Y Hanna; Jeffrey Myers; Vinidh Paleri; Brett Miles; Eric Genden; Antoine Eskander; Danny J Enepekides; Kevin M Higgins; Dale Brown; Douglas B Chepeha; Ian J Witterick; Patrick J Gullane; Jonathan C Irish; Eric Monteiro; David P Goldstein; Ralph Gilbert
Journal:  Cancer       Date:  2020-08-11       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.